← Study Library
RCT · 1993 · n=60
Promisingcounts toward this tierEffects of oral administration of type II collagen on rheumatoid arthritis
Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL · Science
Promisingcounts toward this tier
The landmark that launched oral tolerance as a therapeutic idea. Swollen and tender joint counts fell in the collagen group but not on placebo, and four patients achieved complete remission, with no side effects. Published in Science with an accompanying editorial. Everything since has been an attempt to replicate it.
- Population
- Patients with severe, active rheumatoid arthritis
- Intervention
- Oral chicken type II collagen for 3 months
- Comparator
- Placebo
- Limitations
- Small (n=60) and three months. Rheumatoid arthritis is an autoimmune disease; whether the mechanism transfers to osteoarthritis is a separate and unresolved question. The result did not survive replication — see pmid-8546737, pmid-9485087, pmid-10366113 and pmid-19951408.
Cited by
2 entries reference this study
- Oral tolerance: the rise and fallPRECL.
Supplements → Collagen & building blocks · key study
- Undenatured type II collagen (UC-II)PROM.
Supplements → Collagen & building blocks